Lothar Kappich - Sartorius Aktiengesellscha Member of the Supervisory Board
| SARTF Stock | USD 235.81 8.03 3.53% |
Executive
Dr. Lothar Kappich was Chairman of the Supervisory Board of Sartorius Aktiengesellschaft since July 19, 2017. Prior to that, he was Member of the Supervisory Board at the Company from April 27, 2007. He also serves as Member of the Nomination Committee, the Audit Committee and Chairman of the Executive Task Committee and Conciliation Committee at the Company. He was Managing Director of ECE Projektmanagement GmbH Co. KG. He is a graduate Economist. since 2017.
| Age | 61 |
| Tenure | 7 years |
| Professional Marks | Ph.D |
| Phone | 49 551 308 0 |
| Web | https://www.sartorius.com |
Sartorius Aktiengesellscha Management Efficiency
The company has return on total asset (ROA) of 0.106 % which means that it generated a profit of $0.106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3386 %, meaning that it generated $0.3386 on every $100 dollars invested by stockholders. Sartorius Aktiengesellscha's management efficiency ratios could be used to measure how well Sartorius Aktiengesellscha manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 12 records | EXECUTIVE Age | ||
| Juan DiazCartelle | Microbot Medical | 48 | |
| Ekene Ofodile | Innovative Eyewear | N/A | |
| Jaoquin Abondano | Innovative Eyewear | 40 | |
| Mark Fox | Utah Medical Products | N/A | |
| Paul Goode | GlucoTrack | 55 | |
| Ben Scheu | Sharps Technology | N/A | |
| Drinda Benjamin | GlucoTrack | 48 | |
| Marcena Clawson | Utah Medical Products | N/A | |
| James Cardwell | GlucoTrack | 63 | |
| Mark Tapsak | GlucoTrack | 55 | |
| Brian Koopman | Utah Medical Products | 54 | |
| James Thrower | GlucoTrack | 54 | |
Management Performance
| Return On Equity | 0.34 | |||
| Return On Asset | 0.11 |
Sartorius Aktiengesellscha Leadership Team
Elected by the shareholders, the Sartorius Aktiengesellscha's board of directors comprises two types of representatives: Sartorius Aktiengesellscha inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sartorius. The board's role is to monitor Sartorius Aktiengesellscha's management team and ensure that shareholders' interests are well served. Sartorius Aktiengesellscha's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sartorius Aktiengesellscha's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rene Faber, Member of the Executive Board, Head of the Bioprocess Solutions Division | ||
| Reinhard Vogt, Member of the Executive Board | ||
| Michael Dohrmann, Member of the Supervisory Board, Employee Representative | ||
| Petra Kirchhoff, Member of the Supervisory Board, Vice President of Corporate Communications & Investor Relations | ||
| Manfred Werner, Sr Auditing | ||
| Thomas Scheper, Member of the Supervisory Board | ||
| Patricia Spannagel, Head Goettingen | ||
| Rainer Lehmann, CFO, Member of the Executive Board | ||
| Karoline Kleinschmidt, Member of the Supervisory Board, Employee Representative | ||
| Ilke Panzer, Member of the Supervisory Board | ||
| Rashid Maqbool, Head USA | ||
| Lothar Kappich, Member of the Supervisory Board | ||
| Mei Wang, Head China | ||
| Annette Becker, Member of the Supervisory Board, Employee Representative | ||
| Gerd Krieger, Member of the Supervisory Board | ||
| Manfred Zaffke, Vice Chairman of the Supervisory Board | ||
| Joachim Kreuzburg, Chairman of the Executive Board, CEO, Executive for Labor Relations | ||
| Manohar Kuppusami, Head India | ||
| Gerry MacKay, Vice President of Marketing Sales and Services | ||
| Uwe Bretthauer, Member of the Supervisory Board, Employee Representative | ||
| Arnold Picot, Chairman of the Supervisory Board | ||
| Guido Oelkers, Member of the Supervisory Board | ||
| John MacKay, Member of the Executive Board, Head of the Lab Products & Services Division | ||
| Klaus Truetzschler, Member of the Supervisory Board | ||
| Dirk Basting, Member of the Supervisory Board | ||
| Joerg Pfirrmann, CFO, Member of the Executive Board | ||
| Daniela Favoccia, Member of the Supervisory Board |
Sartorius Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sartorius Aktiengesellscha a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.34 | |||
| Return On Asset | 0.11 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 27.76 B | |||
| Shares Outstanding | 34.23 M | |||
| Shares Owned By Insiders | 84.78 % | |||
| Shares Owned By Institutions | 3.73 % | |||
| Price To Earning | 58.19 X | |||
| Price To Book | 11.12 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sartorius Aktiengesellscha in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sartorius Aktiengesellscha's short interest history, or implied volatility extrapolated from Sartorius Aktiengesellscha options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sartorius Aktiengesellschaft. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Sartorius Pink Sheet analysis
When running Sartorius Aktiengesellscha's price analysis, check to measure Sartorius Aktiengesellscha's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Aktiengesellscha is operating at the current time. Most of Sartorius Aktiengesellscha's value examination focuses on studying past and present price action to predict the probability of Sartorius Aktiengesellscha's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Aktiengesellscha's price. Additionally, you may evaluate how the addition of Sartorius Aktiengesellscha to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |